Two new Ni(II) complexes, [Ni2L12(C6H5CH2COO)](ClO4)·2CH3CN (1) and [Ni2L12(C6H5CH2COO)2(H2O)]·2H2O (2) have been synthesized by using Ni(ClO4)2·6H2O, a tridentate NNO donor reduced Schiff base ligand, HL1 = [(3-dimethylamino-propylamino)-methyl]-phenol and phenylacetic acid as co-ligand. Both complexes have been characterized by single crystal X-ray crystallography, electronic and IR spectroscopy. Structural analysis reveals that Ni(II) ions possess distorted octahedral geometry in both complexes 1-2. Bis-µ2-phenoxido bridged complex 1 has one syn-syn phenylacetate bridging, whereas complex 2 possesses similar type of structure with addition terminal coordination (Syn-monodentate-h1 mode) by another phenylacetate molecule.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: